Pharmadrug Inc. (CSE: PHRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.0200
0.00 (0.00%)
Sep 26, 2024, 2:14 PM EDT

Pharmadrug Statistics

Total Valuation

Pharmadrug has a market cap or net worth of CAD 2.15 million. The enterprise value is 3.53 million.

Market Cap 2.15M
Enterprise Value 3.53M

Important Dates

The next estimated earnings date is Wednesday, October 30, 2024.

Earnings Date Oct 30, 2024
Ex-Dividend Date n/a

Share Statistics

Pharmadrug has 107.70 million shares outstanding. The number of shares has increased by 59.49% in one year.

Shares Outstanding 107.70M
Shares Change (YoY) +59.49%
Shares Change (QoQ) +5.77%
Owned by Insiders (%) 0.04%
Owned by Institutions (%) n/a
Float 106.66M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.27
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.13

Current Ratio 0.13
Quick Ratio 0.10
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.68

Financial Efficiency

Return on equity (ROE) is -377.99% and return on invested capital (ROIC) is -16.77%.

Return on Equity (ROE) -377.99%
Return on Assets (ROA) -13.15%
Return on Capital (ROIC) -16.77%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +300.00% in the last 52 weeks. The beta is 2.75, so Pharmadrug's price volatility has been higher than the market average.

Beta (5Y) 2.75
52-Week Price Change +300.00%
50-Day Moving Average 0.02
200-Day Moving Average 0.03
Relative Strength Index (RSI) 49.16
Average Volume (20 Days) 145,314

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -1.34M
Pretax Income -14.36M
Net Income -13.29M
EBITDA -1.29M
EBIT -1.34M
Earnings Per Share (EPS) -0.16
Full Income Statement

Balance Sheet

The company has 149,546 in cash and 1.34 million in debt, giving a net cash position of -1.19 million or -0.01 per share.

Cash & Cash Equivalents 149,546
Total Debt 1.34M
Net Cash -1.19M
Net Cash Per Share -0.01
Equity (Book Value) -1.18M
Book Value Per Share -0.01
Working Capital -1.75M
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.20M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Pharmadrug does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -59.49%
Shareholder Yield -59.49%
Earnings Yield -821.40%
FCF Yield n/a

Stock Splits

The last stock split was on October 24, 2023. It was a reverse split with a ratio of 0.1428571.

Last Split Date Oct 24, 2023
Split Type Reverse
Split Ratio 0.1428571

Scores

Altman Z-Score n/a
Piotroski F-Score n/a